Adults with certain types of cancer may receive chemotherapy treatment with a drug called BiCNU® (carmustine). This prescription medicine is specifically approved for use in adults and is licensed to treat the following cancers:
BiCNU belongs to a group of medicines known as alkylating agents. It contains the active drug carmustine, which is sometimes referred to as BCNU because its chemical name is bis-chloroethylnitrosourea.
This medicine works by interfering with the process needed for cells to grow and multiply. BiCNU is given as a slow injection into a vein (intravenous, or IV, infusion). Side effects may include nausea, vomiting, and low blood cell counts.
(To learn more about this chemotherapy drug, including more details on how it works, click BiCNU.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed August 7, 2012.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed August 7, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click